KKR (KKR) has received European Commission approval to acquire sole control of Sweden-based Intressenter Holding, or Karo Healthcare under the EU Merger Regulation, the commission said Wednesday.
The acquisition, primarily involving the consumer healthcare industry, was reviewed under a simplified merger procedure by the commission, which found no competition concerns due to the companies' limited market positions resulting from the proposed deal, according to the statement.
Price: 143.82, Change: +1.16, Percent Change: +0.81
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.